Co-amoxiclav

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instanceOf gptkb:antibiotic
gptkbp:activeIngredient gptkb:amoxicillin
gptkb:clavulanic_acid
gptkbp:administeredBy animals
humans
gptkbp:alsoKnownAs amoxicillin/clavulanic acid
gptkbp:approvalYear 1984
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode J01CR02
gptkbp:brand gptkb:Curam
gptkb:Synulox
gptkb:Augmentin
gptkb:Clavamox
gptkbp:category gptkb:beta-lactam_antibiotics
penicillin antibiotics
beta-lactamase inhibitors
gptkbp:chemicalFormula C16H19N3O5S (amoxicillin), C8H9NO5 (clavulanic acid)
gptkbp:combinationTherapy true
gptkbp:contraindication penicillin allergy
gptkbp:developedBy gptkb:Beecham
gptkbp:discoveredIn 1981
gptkbp:drugInteraction gptkb:warfarin
gptkb:methotrexate
allopurinol
oral contraceptives
gptkbp:eliminationHalfLife 1 hour
gptkbp:excretion renal
https://www.w3.org/2000/01/rdf-schema#label Co-amoxiclav
gptkbp:indication urinary tract infections
respiratory tract infections
dental infections
skin and soft tissue infections
bone and joint infections
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits bacterial cell wall synthesis
inhibits beta-lactamase enzymes
gptkbp:overdoseSymptoms renal dysfunction
gastrointestinal upset
gptkbp:pregnancyCategory B (US)
gptkbp:prescribes adults
children
gptkbp:routeOfAdministration oral
intravenous
gptkbp:sideEffect nausea
diarrhea
rash
liver dysfunction
gptkbp:spectrumOfActivity broad-spectrum
gptkbp:storage room temperature
gptkbp:usedFor bacterial infections
gptkbp:WHOModelListOfEssentialMedicines true
gptkbp:bfsParent gptkb:Augmentin
gptkb:Zentiva
gptkbp:bfsLayer 7